You are here

Chronic Stress

Chronic Stress


eISSN: 24705470 | ISSN: 24705470 | Current volume: 7 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Published since 2016
  • Avg. 40 days from submission to first decision 
  • Single-blind peer review policy

Chronic Stress is an open access, peer reviewed international journal publishing original and review articles related to all aspects of stress, including preclinical and clinical studies of stress-related psychiatric disorders (e.g. mood, anxiety, and trauma disorders). Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).


Submission Information

Submit your manuscript at http://mc.manuscriptcentral.com/chronicstress.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.

The APC for this journal is currently $2000 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to the Managing Editor at lynnette.averill@yale.edu or Assistant Managing Editor at prerana.purohit@yale.edu.

Chronic Stress is a peer-reviewed, open-access, journal publishing original and review articles related to all aspects of stress, including preclinical and clinical studies of stress-related psychiatric disorders (e.g. mood, anxiety, and trauma disorders).

Chronic Stress focuses on the neurobiology, prevention, assessment, and treatment of the behavioral and biological effect of stress. Progress in the field of psychiatry and clinical neuroscience has been hampered by the lack of replicable biosignatures of diagnosis, biomarkers of treatment response, and biological surrogate treatment endpoints. This is especially affected by the fact that psychiatric diagnoses are heterogeneous syndromes and difficult to model preclinically. Conversely, prolonged stress has long been studied preclinically and is a major component of most psychiatric disorders, with a constellation of clinical biological abnormalities that appear to be disease non-specific and primarily related to the negative effects of prolonged stress (e.g. gray matter abnormalities). Chronic Stress highlights translational and clinical reports focusing on biomarkers and treatment of prolonged stress, regardless of the psychiatric diagnosis.

Chronic Stress was created to publish research intended to advance our understanding of the nature and mechanisms of stress, as well as, to contribute to the identification of the biological, behavioral, and social interventions to prevent, assess, and treat the negative effects of stress and to foster and build resilience. It aims to be a leading resource for by scientists, psychiatrists, psychologists, social workers, biostatisticians, epidemiologists, occupational researchers, and physicians of all medical specialties. Types of papers currently being accepted for peer-review include original research papers, brief reports, research reviews, auto-commentary, correspondence, and commentary.

Topics include, but are not limited to:

  • The neurobiology of mental illnesses
  • The role and the neurobiology of resilience
  • The effects of trauma and stress on the brain
  • The systemic effects of trauma and stress
  • The relationship between mental illnesses and trauma and stress
  • The relationship between medical illnesses and trauma and stress
  • Biological, behavioral, and social interventions to prevent or treat the negative effects of trauma and stress
  • Epidemiology of trauma and stress
  • Social impact of trauma and stress

For more information on the requirements for these papers, please read the complete Submission Guidelines.

Manuscript Submission

Editor
Elbert Geuze, PhD Utrecht University Medical Center, Netherlands
Associate Editor
Lynnette Averill, PhD Baylor College of Medicine, USA
Prakash Chandra, MD University of Missouri-Kansas City, USA
John H. Krystal, MD Yale University, USA
Assistant Managing Editor
Chris Averill Baylor College of Medicine, USA
Prerana Purohit, BA Yale University, USA
Managing Editor
Review Editors
Teddy Akiki, MD Yale School of Medicine, USA
Hani Chanbour, MD Vanderbilt University Medical Center, USA
Zahra Jafari, PhD University of Lethbridge, Canada
Gianluca Lavanco, PhD University of Palermo, Italy
Reggie H. Lee, PhD LSU Health Sciences Center, USA
Anahita Bassir Nia Yale School of Medicine, USA
Foster Olive, PhD Arizona State University, USA
Jason J. Radley, PhD University of Iowa, USA
Vadim Tseilikman, PhD South Ural State University, Russia
Terril Verplaetse, PhD Yale School of Medicine, USA
Wei Wang, PhD Norwegian University of Science and Technology, Norway
Yohannes W. Woldeamanuel, MD Stanford University School of Medicine, USA
Editorial Board
Elizabeth (Birdie) Shirtcliff University of Oregon, USA
Manik Ahuja, PhD East Tennessee State University, United States
Ana Andreazza, Pharm, PhD University of Toronto, Canada
Lior Carmi, PhD Sheba Medical Center, Israel
Hagit Cohen, PhD Ben-Gurion University of the Negev, Israel
Jeremy Coplan, MD State University of New York Downstate, USA
Margaret T. Davis, PhD Yale University, Connecticut, USA
Irina Esterlis, PhD Yale University, USA
Adriana Feder, MD Icahn School of Medicine at Mount Sinai, New York, NY, USA
Rodrigo Grassi-Oliveira, MD, PhD Pontifical Catholic University of Rio Grande do Sul, Brazil
Jenny Guidi, PsyD, PhD University of Bologna, Italy
Neil Harrison, PhD University of Sussex, UK
Mathilde Husky, PhD Université de Bordeaux, France
Alessandro Ieraci, PhD University of Milan, Italy
Manish Jha, MD UT Southwestern, Texas, USA
Siegfried Kasper, MD Medical University of Vienna, Austria
Nastassja Koen, MBChB, PhD University of Cape Town, South Africa
Christoph Kraus, MD, PhD Medical University of Vienna, Austria
Ruth Lanius, MD, PhD Lawson Health Research Institute, London, Ontario, Canada
Cheng-Ta Li, MD, PhD National Yang-Ming University, Taiwan
Israel Liberzon, PhD Texas A&M College of Medicine, USA
Sanjay Mathew, MD Baylor College of Medicine, USA
Alexander “Sandy” McFarlane, MD University of Adelaide, Australia
Katie McLaughlin, PhD University of Washington, Department of Psychology, USA
Andreas Meyer-Lindenberg, MD, MSc, MBA University of Heidelberg, Germany
Vasiliki Michopoulos, PhD Emory University, Georgia, USA
Euripedes Constantino Miguel, MD University of Sao Paulo, Brazil
Rajendra Morey, MD Duke University, USA
Dominic Murphy King’s College London, UK
James Murrough, MD Icahn School of Medicine, USA
Michelle A. Patriquin, PhD, ABPP The Menninger Clinic, Texas, USA
Robert Pietrzak, PhD Yale University, USA
Maurizio Popoli, PhD University of Milan, Italy
Jason J. Radley, PhD University of Iowa, USA
Ann Rasmusson, MD Boston University, USA
Kerry Ressler, MD, PhD Harvard University, USA
Dr Sanne van Rooij Emory University, USA
Rainer Rupprecht, MD University of Regensburg, Germany
Ramiro Salas, PhD Baylor College of Medicine, Texas, USA
Gerard Sanacora, MD, PhD Yale University, USA
Joao R. Sato, DSc Universidade Federal do ABC, Brazil
Dan J. Stein, MD, PhD University of Cape Town, South Africa
Tung-Ping Su, MD National Yang-Ming University, Taiwan
Heike Tost, MD, PhD Central Institute of Mental Health Mannheim, Germany
Gregers Wegener, MD, PhD, DSc Aarhus University Hospital, Denmark
Douglas Williamson, PhD Duke University, USA
Steven H. Woodward, PhD VA Palo Alto Health Care System, USA
Joseph Zohar, MD Tel Aviv University, Israel
Dr Mirjam van Zuiden University of Utrecht, Netherlands
  • Google Scholar: h-5 index - 11, h-5 median - 13
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/chronicstress to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Please also be sure to look over the submission checklist here before submitting.

    Only manuscripts of sufficient quality that meet the aims and scope of Chronic Stress will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    If you have any questions about publishing with Sage, please visit the Sage Journal Solutions Portal

    Please read the Manuscript Submission Guidelines below before submitting your manuscript here: 

    SUBMIT MANUSCRIPT

    1. Open Access
    2. Article processing charge (APC)
    3. What do we publish?
      3.1 Aims & scope
      3.2 Article types
      3.3 Writing your paper
      3.3.1 Making your article discoverable 
    4. Editorial policies
      4.1 Peer Review Policy
      4.2 Authorship
      4.3 Acknowledgements
      4.3.1 Third Party Submissions
      4.3.2 Writing assistance
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical Trials
      4.8 Reporting guidelines
    5. Publishing policies
      5.1 Publication ethics
      5.1.1 Plagiarism
      5.1.2 Prior publication
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplemental material
      6.4 Reference style
      6.5 Neuroscience- based Nomenclature (NbN-2)
      6.6 English language editing services
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Information required for completing your submission
      7.4 ORCID
      7.5 Permissions
    8. On acceptance and publication
      8.1 Sage Production
      8.2 Online publication
      8.3 Promoting your article
    9. Further information

    1. Open Access

    Chronic Stress is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

    For general information on open access at Sage please visit the Open Access page or view our Open Access FAQs.

    Back to top

    2. Article processing charge (APC)

    If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons licence.

    The article processing charge (APC) for this journal is $2000.

    Back to top

    3. What do we publish?

    3.1 Aims & scope

    Before submitting your manuscript to Chronic Stress, please ensure you have read the Aims & Scope.

    3.2 Article types

    • Original Research should have an abstract of no more that 350 words, be no longer than 4,000 words and have no limits on figures/tables or references.
    • Review articles should have an abstract of no more than 200 words, be no longer than 5,000 words and have no limit on figures/tables or references.
    • Correspondences should have no abstract, be no longer than 750 words, have no more than 1 figure/table and no more than 5 references. There is no APC charge for correspondences as long as they do not go over the word limit.
    • Commentaries should have no abstract, be no longer than 500 words, have no more than 1 figure/table and no more than 3 references.

    Original Research papers should include:

    Title page

    • Title (up to 150 letters and spaces) Running title (up to 60 letters and spaces) Authors(including highest degree)
    • Affiliations (including location of the institution, e.g. New Haven, CT, USA) Emails of allauthors
    • Contact information of corresponding author
    • Number of words and items for each of the following: abstract, text, figures, tables, and references Keywords: 5-10

    Abstract

    • Background (recommended word limit is 80)
    • Methods
    • Results
    • Conclusion (recommended word limit is 80)

    Text

    • Introduction (up to 1,500 words)
    • Methods
    • Results
    • Discussion
    • Conclusion

    Acknowledgments (optional)
    Funding
    Declaration of Conflicting Interests
    References
    Figure legends (if applicable)
    Figures (if applicable)
    Tables (is applicable)
    Supplemental Materials (optional)

    Review, Correspondence, and Commentary papers should include:

    Title page

    • Title (up to 150 letters and spaces)
    • Running title (up to 60 letters and spaces)
    • Authors (including highest degree)
    • Affiliations (including location of the institution, e.g. New Haven, CT, USA)
    • Emails of all authors
    • Contact information of corresponding author
    • Number of words and items for each of the following: abstract, text, figures, tables, and references
    • Keywords: 5-10
    • For Commentaries, add the phrase “Comment on (citation to your original article).” underneath the keywords

    Abstract (unstructured; optional for Correspondence)
    Text (structure is determined by the authors)
    Acknowledgments (optional)
    Funding
    Delcaration of Conflicting Interests
    References
    Figure Legends (if applicable)
    Figures (if applicable)
    Tables (if applicable)

    Original Research: These are reports of original data and findings in a topic within the scope of Chronic Stress. Authors are encouraged to write concise Introduction. Stating the rationale and study hypotheses in the Introduction is required. Supplement Materials are available, however, primary methods and findings should be sufficiently described in the body of the paper. While pilot work of potential significant impact is welcomed, the preliminary nature of the findings should be highlighted throughout the report. Limitations of the study should be mentioned in the Discussion. Authors are discouraged of overstating/over-interpreting the report findings. Brief reports addressing a single or few research questions would be considered.

    Review: These are scholarly reviews of a topic within the scope of Chronic Stress. Authors should avoid excessive jargon. While summarizing the extent literature in tables is encouraged, the text of the review should not be a bibliographic annotation of the published literature. Authors should integrate the data presented, while proposing working models and highlighting the strengths and weakness of the findings, as well as the future directions of the field. High quality figures depicting the presented models are encouraged.

    Correspondence: These are letters to the editors regarding a report or a letter published in Chronic Stress.

    Commentary: Commentaries are by invitation only. These are short summaries of significant recent or forthcoming papers, published at Chronic Stress or elsewhere, that provide additional insights, new interpretations or speculation on the relevant topic. Commentaries may be written in free form, meaning that they do not need to be structured as a research paper, however they must start with an introductory summary of 150-200 words. They should be approximately 500 words and have no more than 3-5 references. Please include keywords for indexing purposes. Figures/tables are encouraged, but no more than one. Please give your commentary a brief title and add the phrase “Comment on (citation to your original article).” underneath the keywords. Commentary material may be peer reviewed at the editor’s discretion.

    Letters to the Editor: A letter to the Editor is a brief communication that either addresses the contents of a published article, 
    or is a correspondence unrelated to a specific article. Its purpose is to make corrections, provide alternative viewpoints, or offer counter arguments. Avoid logical fallacies and ad hominem attacks. Letters to the Editor must be written in a professional tone and include references to support all claims if appropriate.

    A letter to the Editor unrelated to a specific article should not exceed 500 words or have more than 3 references. A letter to the Editor pertaining to a recently published article or to be published concurrently with an article within the journal should not exceed 800 words or have more than 5 references. If an abstract is included, it will automatically be made the first paragraph. Letters should not include figures or research material. Letters to the editor are not charged an APC.

    3.3 Writing your paper

    The Sage Author Gateway has some general advice and on how to get published, plus links to further resources. Sage Author Services also offers authors a variety of ways to improve and enhance their article including English language editing, plagiarism detection, and video abstract and infographic preparation.

    3.3.1 Making your article discoverable 

    When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online

    Back to top

    4. Editorial policies

    4.1 Peer review policy

    The journal’s policy is to have manuscripts reviewed by two expert reviewers. Chronic Stress utilizes a single-anonymize peer review process in which the reviewer’s name and information is withheld from the authorAll manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to the Editor-in-Chief who then makes the final decision.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.

    Chronic Stress is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for Chronic Stress can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors. The list of authors should include all those who can legitimately claim authorship. This is all those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data, (ii) Drafted the article or revised it critically for important intellectual content, (iii) Approved the version to be published, (iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support. 

    4.3.1 Third party submissions

    Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:

    •    Disclose this type of editorial assistance – including the individual’s name, company and level of input 
    •    Identify any entities that paid for this assistance 
    •    Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.

    Where appropriate, Sage reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.

    4.3.2 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    4.4 Funding

    Chronic Stress requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the Sage Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    4.5 Declaration of conflicting interests

    It is the policy of Chronic Stress to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles. Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal. Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.

    4.7 Clinical trials

    Chronic Stress endorses the ICMJE requirement that clinical trials are registered in a WHO approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the Sage Author Gateway.

    5.1.1 Plagiarism

    Chronic Stress and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    5.1.2 Prior publication

    If material has been previously published, it is not generally acceptable for publication in a Sage journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the Sage Author Gateway or if in doubt, contact the Editor at the address given below.

    5.2 Contributor's publishing agreement

    Before publication Sage requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Chronic Stress publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit Sage's OA licenses page.

    Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request. 

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    6.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit Sage’s Manuscript Submission Guidelines.

    Figures supplied in color will appear in color online.

    6.3 Supplemental material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplemental files, which can be found within our Manuscript Submission Guidelines page. 

    6.4 Reference style

    Chronic Stress adheres to the Sage Vancouver reference style. Please review the guidelines on Sage Vancouver to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the Sage Vancouver output file here.

    6.5 Neuroscience- based Nomenclature (NbN-2)

    Chronic Stress encourages the use of Neuroscience-based Nomenclature (NbN-2) terminology for psychotropic medications, as it reflects contemporary pharmacological knowledge, rather than arbitrary descriptors based on indications or chemical structure. Please download the free app for NbN-2 (http://nbnomenclature.org/) and the Instructions for Authors (http://nbnomenclature.org/authors).

    While you are welcome to use NbN-2 throughout the manuscript, as a minimum requirement we ask that on first mention in the paper, substances are referred to by their NbN-2 classification and that all substances studied in the paper receive NbN-2 compliant keywords (e.g. ten pharmacological domains and nine mode of action).

    6.6 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using Sage Language Services. Visit Sage Language Services on our Journal Author Gateway for further information. 

    Back to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    Chronic Stress is hosted on Sage Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/chronicstress to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the Sage Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online

    7.3 Information required for completing your submission

    You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed on the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

    7.4 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process Sage is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

    The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.

    If you do not already have an ORCID iD please follow this link to create one or visit our ORCID homepage to learn more.

    7.5 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the Sage Journal Author Gateway.

    Back to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been check for Sage Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.

    8.1 Sage Production

    Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will made available to the corresponding author via our editing portal Sage Edit, or by email to the corresponding author and should be returned promptly.  Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. 

    8.2 Online publication

    One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all. 

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The Sage Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.

    Back to top

    9. Further information

    Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Chronic Stress editorial office as follows:

    Managing Editor: Lynnette Averill, PhD | lynnette.averill@yale.edu Assistant Managing Editor: Prerana Purohit | prerana.purohit@yale.edu

    Back to top